Investor Connect: Bridging the Gap Between Innovation & Capital

LaunchBio, Browne Consulting, and Silicon Valley Bank, a division of First Citizens Bank, with support by Fondation Ipsen, are pleased to announce their next Investor Connect virtual event with Northpond Ventures.

Northpond is a leading biotech investor, backing transformative companies from seed through Series B while providing strategic guidance to help scale and commercialize innovations. Its team combines scientific, clinical, and financial expertise to support founders in science and healthcare.

Beyond direct investments, Northpond operates Northpond Labs, a translational research platform that partners with Harvard’s Wyss Institute, MIT’s School of Engineering, and Stanford Medicine to fund and advance proof-of-concept programs, turning academic discoveries into commercial ventures.

Applications will be selected based on meeting the following criteria:

Primarily in the US and Europe
Focus on life sciences, biotechnology, diagnostics, digital health, and enabling technologies

Modalities of Interest:

• Gene therapies
• Cell therapies (including non-viral and engineered approaches)
• RNA-based therapeutics
• Protein and antibody engineering
• Synthetic biology
• NGS and molecular diagnostics
• Enabling life science tools and platforms

Therapeutic areas include, but are not limited to:

• Oncology
• Neurology
• Immunology
• Infectious diseases
• Rare diseases
• Other high-impact areas where breakthrough science can significantly advance healthcare

Stage:

Companies seeking Seed, Series A, and Series B (with flexibility for later stage opportunities).

To apply for consideration, click here. Applications are accepted on a rolling basis.